Education
About Us
Working with TipRanks
Follow Us
Noxopharm Ltd. (AU:NOX)
ASX:NOX
Total Valuation
Noxopharm Ltd. has a market cap or net worth of AU$24.84M. The enterprise value is AU$16.97M.
Market CapAU$24.84M
Enterprise ValueAU$16.97M
Share Statistics
Noxopharm Ltd. has 292,237,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding292,237,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Noxopharm Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Noxopharm Ltd. is ―. Noxopharm Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Noxopharm Ltd. had revenue of 2.40M and earned -3.58M in profits. Earnings per share was -0.01.
Revenue2.40M
Gross Profit-534.81K
Operating Income-7.54M
Pretax Income-5.98M
Net Income-3.58M
EBITDA-5.95M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -684.31K and capital expenditures 0.00, giving a free cash flow of -684.31K billion.
Operating Cash Flow-684.31K
Free Cash Flow-684.31K
Free Cash Flow per Share>-0.01
Dividends & Yields
Noxopharm Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.82
52-Week Price Change33.33%
50-Day Moving Average0.08
200-Day Moving Average0.09
Relative Strength Index (RSI)53.62
Average Volume (3m)66.03K
Important Dates
Noxopharm Ltd. upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend Date―
Financial Position
Noxopharm Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Noxopharm Ltd. has paid -2.40M in taxes.
Income Tax-2.40M
Effective Tax Rate―
Enterprise Valuation
Noxopharm Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Noxopharm Ltd. has AU$2.32M in cash and marketable securities with AU$3.59M in debt, giving a net cash position of -AU$2.32M billion.
Cash & Marketable SecuritiesAU$2.32M
Total DebtAU$3.59M
Net Cash-AU$2.32M
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Noxopharm Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―